Sponsored By
BRIEF-Crispr Therapeutics AG shares open at $15 in debut, above IPO price of $14/shrBRIEF-Crispr Therapeutics AG shares open at $15 in debut, above IPO price of $14/shr
October 19, 2016
1 Min Read
Oct 19 (Reuters) -
* Crispr Therapeutics AG shares open at $15 in debut, above IPO price of $14 per share Further company coverage:
Latest news
Apr 1 - Apr 2, 2025
Apr 1 - Apr 2, 2025
Learn from top leaders tackling growth, pay, and personnel challenges daily.
Learn More